(Q46933265)

26 December 2017

title

Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines (English)

1 reference

26 December 2017

main subject

immunization

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

author name string

Girishchandra B Patel

1

1 reference

26 December 2017

Hongyan Zhou

2

1 reference

26 December 2017

Amalia Ponce

3

1 reference

26 December 2017

Wangxue Chen

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

5 October 2007

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

25

1 reference

26 December 2017

issue

51

1 reference

26 December 2017

page(s)

8622-8636

1 reference

26 December 2017

Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Current options for vaccine delivery systems by mucosal routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Mucosal vaccines: the promise and the challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Recent advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Liposomes and ISCOMS as vaccine formulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Immunomodulators and delivery systems for vaccination by mucosal routes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Vaccination strategies for mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Novel generations of influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

New generation of mucosal adjuvants for the induction of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Structures of archaebacterial membrane lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeosome immunostimulatory vaccine delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Recent advances in structural research on ether lipids from archaea including comparative and physiological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeobacterial ether lipid liposomes as vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

On the revised structure of the major phospholipid of Halobacterium salinarium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeosomes as adjuvants for combination vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Intranasal immunization with liposomes induces strong mucosal immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Targeting immune response induction with cochleate and liposome-based vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Proteoliposome derived cochleate as novel adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Comparative properties and methods of preparation of lipid vesicles (liposomes).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Safety of archaeosome adjuvants evaluated in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

Recent advances with liposomes as pharmaceutical carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.042

10.1016/J.VACCINE.2007.09.042

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017